Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02970110 · ClinicalTrials.gov registry record
Specimen Collection Study for H. Pylori Testing
A clinical trial of Helicobacter Infections, sponsored by Biomerica.
- Completed
- Registry status
- 98
- Enrollment target
- 4
- Study locations
NCT02970110: Completed study of Helicobacter Infections, sponsored by Biomerica.
NCT02970110 is a study of Helicobacter Infections that has completed, run by Biomerica. The registered enrollment target is 98 participants. The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02970110, a study of Helicobacter Infections, has completed, sponsored by Biomerica.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objective of this study is to acquire human specimens from subjects undergoing routine endoscopy with gastric biopsy for the diagnosis of active H. pylori infection.
Primary Outcome
This study is designed to collect specimens to supplement repository specimens for product validation purposes. The endoscopy results and specimens will be used in a future clinical trial of a non-invasive in vitro diagnostic assay for the detection of H. pylori antigen. institutional review board approval is sought in order to be able to use human specimens for validation of in vitro diagnostics.
Conditions Studied
Study Locations (4)
Arizona
- Del Sol Research Management, Inc. - Tucson
California
- University of Southern California - Los Angeles
Florida
- Medley Research Associates - Medley
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2017-02-27 |
| Est. Completion | 2020-03-01 |
What the finished NCT02970110 record still lists
NCT02970110 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target.
The record links to 1 condition, with Helicobacter Infections appearing as the primary indexed condition, and to 0 interventions.
NCT02970110 reports a single indexed study location in Arizona, California, Florida.
Frequently Asked Questions
What is clinical trial NCT02970110 about?
NCT02970110 is a clinical study titled "Specimen Collection Study for H. Pylori Testing". The objective of this study is to acquire human specimens from subjects undergoing routine endoscopy with gastric biopsy for the diagnosis of active H. pylori infection.
What is the current status of trial NCT02970110?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2017-02-27. Estimated completion is 2020-03-01.
What conditions does trial NCT02970110 study?
This clinical trial studies the following conditions: Helicobacter Infections.
Who is sponsoring clinical trial NCT02970110?
This trial is sponsored by Biomerica, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02970110 being conducted?
This trial has 4 study locations across Arizona, California, Florida, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Helicobacter Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI